Enveric Biosciences, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enveric Biosciences, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Enveric Biosciences, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 8.99M shares, a 312% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.99M +6.81M +312% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.88M +5.74M +268% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 7.29M +5.22M +251% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.74M +661K +31.8% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 2.18M +104K +4.99% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.14M +1.09M +103% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 2.08M -50.5M -96.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 2.08M +1.43M +219% Dec 31, 2022 10-K 2024-03-26
Q3 2022 2.08M -29.3M -93.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 1.05M -20.4M -95.1% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 52.6M +33.2M +171% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 652K -9.44M -93.5% Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 31.4M +25.6M +447% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 21.4M +16.3M +315% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 19.4M +16.2M +499% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 10.1M +4.78M +90.1% Dec 31, 2020 10-K 2022-03-31
Q3 2020 5.74M -57.1M -90.9% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 5.16M -47.3M -90.2% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 3.25M -47.1M -93.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 5.31M +3.62M +214% Dec 31, 2019 10-K 2021-04-01
Q3 2019 62.8M +39.9M +174% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 52.4M +33.4M +176% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 50.3M +31.5M +168% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 1.69M -16.5M -90.7% Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 22.9M +7.09M +44.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 19M +4.36M +29.8% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 18.8M +4.21M +28.9% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 18.2M +4.28M +30.8% Dec 31, 2017 10-K 2019-03-26
Q3 2017 15.9M +2.37M +17.6% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 14.7M +1.16M +8.64% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 14.6M +2.71M +22.8% Mar 31, 2017 10-Q/A 2017-05-15
Q4 2016 13.9M +2.01M +16.9% Dec 31, 2016 10-K 2018-04-02
Q3 2016 13.5M +1.85M +15.9% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 13.5M +1.85M +15.9% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 11.9M +1.88M +18.8% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 11.9M -3.54M -22.9% Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 11.6M -3.77M -24.5% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 11.6M -3.77M -24.5% Jun 30, 2015 10-Q/A 2015-08-18
Q1 2015 9.99M +3.4M +51.5% Mar 31, 2015 10-KT 2016-03-15
Q4 2014 15.4M +3.27M +26.9% Dec 31, 2014 10-Q 2015-05-14
Q3 2014 15.4M +3.27M +26.9% Sep 30, 2014 10-Q/A 2014-11-14
Q2 2014 15.4M +3.27M +26.9% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 6.6M -5.54M -45.7% Mar 31, 2014 10-KT 2016-03-15
Q4 2013 12.1M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 12.1M 0 0% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 12.1M 0 0% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 12.1M 0 0% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 12.1M +25 0% Dec 31, 2012 10-K 2014-03-28
Q3 2012 12.1M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 12.1M +5.64M +86.8% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 12.1M Mar 31, 2012 10-Q/A 2012-05-10
Q4 2011 12.1M +5.64M +86.8% Dec 31, 2011 10-K 2013-02-28
Q3 2011 12.1M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 6.5M Jun 30, 2011 10-Q 2011-08-02
Q4 2010 6.5M Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.